These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33358149)

  • 1. Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.
    Rini B; Abel EJ; Albiges L; Bex A; Brugarolas J; Bukowski RM; Coleman JA; Drake CG; Figlin RA; Futreal A; Hammers H; Powles T; Rathmell WK; Ricketts CJ; Turajlic S; Wood CG; Leibovich BC
    Clin Genitourin Cancer; 2021 Apr; 19(2):167-175. PubMed ID: 33358149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in renal cell cancer immunotherapy.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios.
    Cetin B; Kosar A
    Int Urol Nephrol; 2019 Dec; 51(12):2107-2117. PubMed ID: 31468288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of Systemic Therapy Use for Renal Cell Carcinoma in the United States.
    Ferry EK; Minnillo BJ; Maurice MJ; Abouassaly R; Zhu H
    Urology; 2015 Jun; 85(6):1399-403. PubMed ID: 26099886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory Therapies for Renal Cell Carcinoma.
    Liu M; Wu H; Shangguan D; Jiang Y; Li X; Liu S; Zhou B; Yin T; Gong Z
    Protein Pept Lett; 2018; 25(6):534-547. PubMed ID: 29848257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study.
    Pérez-Gracia JL; Castellano D; Climent MÁ; Mellado B; Suárez C
    Med Oncol; 2019 Feb; 36(3):29. PubMed ID: 30783817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on "Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α." Tsimafeyeu I, Zart JS, Chung B, Kidney Cancer Research Bureau, Moscow, Russian Federation.: BJU Int 2013; 112(1):32-8. [Epub 2013 Jun 7]. doi: 10.1111/bju.12107.
    Boorjian S
    Urol Oncol; 2014 May; 32(4):514-5. PubMed ID: 24767689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell cancer: overview of the current therapeutic landscape.
    Erman M; Benekli M; Basaran M; Bavbek S; Buyukberber S; Coskun U; Demir G; Karabulut B; Oksuzoglu B; Ozkan M; Sevinc A; Yalcin S
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):955-68. PubMed ID: 27548347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the biology and management of renal cell carcinoma.
    Dutcher JP
    J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics.
    Wong MK
    Curr Oncol Rep; 2008 May; 10(3):259-63. PubMed ID: 18765157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research.
    Mosillo C; Ciccarese C; Bimbatti D; Fantinel E; Volta AD; Bisogno I; Zampiva I; Santoni M; Massari F; Brunelli M; Montironi R; Tortora G; Iacovelli R
    Cancer Treat Rev; 2018 Jun; 67():29-33. PubMed ID: 29753244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
    Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating biomarkers in advanced renal cell carcinoma: clinical applications.
    Hernandez-Yanez M; Heymach JV; Zurita AJ
    Curr Oncol Rep; 2012 Jun; 14(3):221-9. PubMed ID: 22434312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
    Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present state and the future perspective of immunotherapy of renal cell carcinoma].
    Kawashima H
    Nihon Rinsho; 2015 Jan; 73(1):167-74. PubMed ID: 25626324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
    Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
    Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2.
    Cersosimo RJ
    Am J Health Syst Pharm; 2009 Sep; 66(18):1625-33. PubMed ID: 19729567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
    Grünwald V; Eberhardt B; Bex A; Flörcken A; Gauler T; Derlin T; Panzica M; Dürr HR; Grötz KA; Giles RH; von Falck C; Graser A; Muacevic A; Staehler M
    Nat Rev Urol; 2018 Aug; 15(8):511-521. PubMed ID: 29904105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.